Detalles de la búsqueda
1.
Relevance of ATM Status in Driving Sensitivity to DNA Damage Response Inhibitors in Patient-Derived Xenograft Models.
Cancers (Basel)
; 15(16)2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627223
2.
Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5ß1: part 1.
Bioorg Med Chem Lett
; 22(12): 4111-6, 2012 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22575869
3.
Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5ß1: part 2.
Bioorg Med Chem Lett
; 22(12): 4117-21, 2012 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22572578
4.
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib.
Cancer Res
; 82(6): 1140-1152, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35078817
5.
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.
J Immunother Cancer
; 10(4)2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35387780
6.
Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition.
Mol Cancer Ther
; 20(6): 1080-1091, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785652
7.
Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.
Mol Cancer Ther
; 19(1): 13-25, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31534013
8.
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery.
J Immunother Cancer
; 7(1): 328, 2019 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31779705
9.
Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma.
Mol Cancer Ther
; 18(5): 909-919, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30872381
Resultados
1 -
9
de 9
1
Próxima >
>>